There is no conclusive long-term human data, so its recommended to use BPC-157 under the guidance of a healthcare provider
That is an important caveat
Rechtlich ist die Lage uneinheitlich
Typically, this irritation leads to an inflammatory response, but administering BPC-157 beforehand seemed to lessen that response in a dose-dependent manner [6]
A more comprehensive MCAS treatment approach may be worth exploring if: you have multisystem symptoms that seem inflammatory or allergy-like antihistamines only partly help triggers feel broad, inconsistent, or hard to predict food reactivity has become increasingly limiting digestive symptoms are a major part of the problem stress clearly worsens flares you suspect histamine burden, MCAS, or mast cell instability but want a more complete evaluation This kind of approach may also be relevant for patients who feel caught between diagnoses, such as those told they have IBS, sensitivities, chronic inflammation, or unexplained immune symptoms without a clear unifying framework
Patients can continue with their usual activities while undergoing treatment
